These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 36968851)
1. Presumptive Rhino-Orbital Mucormycosis Secondary to Corticosteroid Therapy in a Diabetic Patient With COVID-19 Infection. Sidhu JK; Wan Hitam WH; Ahmad Tajudin LS Cureus; 2023 Feb; 15(2):e35199. PubMed ID: 36968851 [TBL] [Abstract][Full Text] [Related]
2. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287 [TBL] [Abstract][Full Text] [Related]
3. Rhino-orbital mucormycosis in a patient with no susceptibility following P.vivax malaria infection-a case report. Prasad S; Gaur A; Mehta A; Kaushal N BMC Ophthalmol; 2022 Oct; 22(1):389. PubMed ID: 36183076 [TBL] [Abstract][Full Text] [Related]
4. Orbital Apex Syndrome Due to Mucormycosis - Missed on Initial MRI. Marzoughi S; Chen T Neurohospitalist; 2022 Jan; 12(1):127-130. PubMed ID: 34950400 [TBL] [Abstract][Full Text] [Related]
5. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India. Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435 [TBL] [Abstract][Full Text] [Related]
6. Rhino-Orbital Cerebral Mucormycosis in a Non-diabetic Patient Following COVID-19 Infection: A Case Report and Literature Review. Niazi M; Vittorino I; Thwe H; Alam B; Awosika AO; Omole AE Cureus; 2022 Dec; 14(12):e32884. PubMed ID: 36699798 [TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124 [TBL] [Abstract][Full Text] [Related]
10. Diabetic ketoacidosis and coronavirus disease 2019-associated mucormycosis: a case report. Monroig V; Tarquinio KM J Med Case Rep; 2022 Oct; 16(1):400. PubMed ID: 36316719 [TBL] [Abstract][Full Text] [Related]
11. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study. Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988 [TBL] [Abstract][Full Text] [Related]
12. Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report. Alemayehu FM; Abate HK; Soboka TA; Huluka DK; Worke AB; Abrie MT; Dibaba DK; Asnake YB Int Med Case Rep J; 2022; 15():251-257. PubMed ID: 35615254 [TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Rhino Orbital Mucormycosis. Patade Y; G R Cureus; 2022 Dec; 14(12):e33145. PubMed ID: 36721573 [TBL] [Abstract][Full Text] [Related]
14. Acute Kidney Injury Following Posaconazole for Mucormycosis: SARS-CoV-2 as a Back-Seat Driver. Noor M; Amin S; Rahim F; Ali B; Zafar S Cureus; 2022 Jul; 14(7):e27018. PubMed ID: 35989786 [TBL] [Abstract][Full Text] [Related]
15. Acute orbital apex syndrome and rhino-orbito-cerebral mucormycosis. Anders UM; Taylor EJ; Martel JR; Martel JB Int Med Case Rep J; 2015; 8():93-6. PubMed ID: 25945068 [TBL] [Abstract][Full Text] [Related]
16. Rhino-orbital mucormycosis in COVID-19 (Corona Virus Disease): A case report. Kanaparti A; Alwala A; Chaitanya NC; Chikte D; Jakkula N; Balaindra M J Family Med Prim Care; 2022 Jun; 11(6):3321-3325. PubMed ID: 36119166 [TBL] [Abstract][Full Text] [Related]
17. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
18. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center. Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975 [No Abstract] [Full Text] [Related]
19. Rhino-orbital Mucormycosis as a complication of severe COVID-19 pneumonia. Alamin MA; Abdulgayoom M; Niraula S; Abdelmahmuod E; Ahmed AO; Danjuma MI IDCases; 2021; 26():e01293. PubMed ID: 34603963 [TBL] [Abstract][Full Text] [Related]